Drug Interactions Database

3916 interactions from BNF 85 - Check your medicines

Source: BNF 85
erythromycin abemaciclib

increases exposure

Unknown Study
erythromycin acalabrutinib

increases exposure

Unknown Study
erythromycin alphablockers

increases exposure

Unknown Theoretical
erythromycin alprazolam

increases exposure

Unknown Study
erythromycin antifungals,azoles

increases exposure

Unknown Theoretical
erythromycin antihistamines,non-sedating

increases exposure

Unknown Theoretical
erythromycin avapritinib

increases exposure

Unknown Study
erythromycin axitinib

increases exposure

Unknown Study
erythromycin bedaquiline

increases exposure

Unknown Theoretical
erythromycin benzodiazepines

increases exposure

Unknown Study
erythromycin brigatinib

increases exposure

Unknown Study
erythromycin bromocriptine

increases exposure

Unknown Theoretical
erythromycin cabazitaxel

increases exposure

Unknown Theoretical
erythromycin ceritinib

increases exposure

Unknown Study
erythromycin ciclosporin

increases exposure

Unknown Study
erythromycin cilostazol

increases exposure

Unknown Study
erythromycin cobimetinib

increases exposure

Unknown Study
erythromycin colchicine

increases exposure

Unknown Study
erythromycin dabrafenib

increases exposure

Unknown Study
erythromycin darifenacin

increases exposure

Unknown Study
erythromycin dasatinib

increases exposure

Unknown Study
erythromycin dienogest

increases exposure

Unknown Study
erythromycin diltiazem

increases exposure

Unknown Theoretical
erythromycin dipeptidylpeptidase-

increases exposure

Unknown Study
erythromycin docetaxel

increases exposure

Unknown Study
erythromycin dopaminereceptoragonists

increases exposure

Unknown Theoretical
erythromycin elexacaftor

increases exposure

Unknown Theoretical
erythromycin endothelinreceptorantagonists

increases exposure

Unknown Theoretical
erythromycin entrectinib

increases exposure

Unknown Theoretical
erythromycin eplerenone

increases exposure

Unknown Study
erythromycin ergometrine

increases risk of ergotism

Unknown Theoretical
erythromycin ergotamine

increases risk of ergotism

Unknown Theoretical
erythromycin erlotinib

increases exposure

Unknown Study
erythromycin fesoterodine

increases exposure

Unknown Study
erythromycin finerenone

increases exposure

Unknown Study
erythromycin gefitinib

increases exposure

Unknown Study
erythromycin guanfacine

increases concentration

Unknown Theoretical
erythromycin ibrutinib

increases exposure

Unknown Study
erythromycin imatinib

increases exposure

Unknown Theoretical
erythromycin isavuconazole

increases exposure

Unknown Theoretical
erythromycin lapatinib

increases exposure

Unknown Study
erythromycin lurasidone

increases exposure

Unknown Study
erythromycin macitentan

increases exposure

Unknown Theoretical
erythromycin methadone

increases exposure

Unknown Theoretical
erythromycin midostaurin

increases exposure

Unknown Theoretical
erythromycin mineralocorticoidreceptorantagonists

increases exposure

Unknown Study
erythromycin mizolastine

increases exposure

Unknown Theoretical
erythromycin mobocertinib

increases exposure

Unknown Study
erythromycin naloxegol

increases exposure

Unknown Study
erythromycin neratinib

increases exposure

Unknown Study
Important: This database uses data from the British National Formulary (BNF 85). It is for informational purposes only and is not a substitute for professional medical advice.